Corcept Therapeutics Incorporated (LSE: 0I3Q) has a market capitalization of $12.12B. Last close $115.82 (as of 2026-10-21); 52-week range $28.67 to $126.57. ORTEX data as of 2026-10-20: short interest is 1.24% of free float, 1,772.7 days to cover and the average cost to borrow is 0.39%.